IndustryPayments
Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · as published 2026-01-23 View official record Methodology

Covered recipient · General Payments record

CARTER T DAVIS

Allopathic & Osteopathic Physicians Internal Medicine Hematology & Oncology

NPI
1407146418
CMS profile
3120894
Location
NEW ORLEANS, LA

General Payments · PY2018–2024

$45,955.20

  • Reported across 134 records
  • CMS publication 2026-01-23

Latest program year · PY2024

$19,703.80

54 records · 0 disputed

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How these totals are calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

Related groups: Hematology & Oncology LA All categories

By nature of payment

PY2024 · sorted by reported total

Nature of paymentAmountRecords
Consulting Fee $15,701.00 11
Food and Beverage $2,433.08 37
Travel and Lodging $1,569.72 6

By paying entity

PY2024 · sorted by reported total

Paying entityAmountRecords
ABBVIE INC. $7,741.99 15
Regeneron Pharmaceuticals, Inc. $7,670.21 17
E.R. Squibb & Sons, L.L.C. $2,099.50 3
TAIHO ONCOLOGY, INC. $1,100.00 1
ADC Therapeutics America, Inc. $301.13 4
Celgene Corporation $249.33 4
Kite Pharma, Inc. $136.11 1
GlaxoSmithKline, LLC. $94.96 1
Genentech, Inc. $93.79 1
Genentech USA, Inc. $71.63 1
BeiGene USA, Inc. $59.85 3
Genmab U.S., Inc. $58.35 2
Janssen Scientific Affairs, LLC $26.95 1

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2018 $699.67 7
PY2019 $120.67 7
PY2020 $354.27 5
PY2021 $129.16 2
PY2022 $8,769.01 24
PY2023 $16,178.62 35
PY2024 $19,703.80 54

Payment records · PY2024 (54)

Sorted by paying entity, then date · as published by CMS

Program year 2024 201820192020202120222023 Record-level detail is published for PY2024; earlier years are summarised in “By program year”.
Paying entity Amount Date Nature of payment Dispute status Published Record ID Source
ABBVIE INC. $100.86 01/31/2024 Food and Beverage Undisputed 01/23/2026 1103607278 CMS
ABBVIE INC. $124.41 03/02/2024 Food and Beverage Undisputed 01/23/2026 1103607280 CMS
ABBVIE INC. $17.15 03/14/2024 Food and Beverage Undisputed 01/23/2026 1103607282 CMS
ABBVIE INC. $18.01 04/08/2024 Food and Beverage Undisputed 01/23/2026 1103607284 CMS
ABBVIE INC. $104.99 04/08/2024 Food and Beverage Undisputed 01/23/2026 1103607286 CMS
ABBVIE INC. $15.89 05/06/2024 Food and Beverage Undisputed 01/23/2026 1103607288 CMS
ABBVIE INC. $116.68 05/09/2024 Food and Beverage Undisputed 01/23/2026 1103607290 CMS
ABBVIE INC. $37.20 05/10/2024 Food and Beverage Undisputed 01/23/2026 1103607292 CMS
ABBVIE INC. $124.16 05/21/2024 Food and Beverage Undisputed 01/23/2026 1103607294 CMS
ABBVIE INC. $950.00 06/05/2024 Consulting Fee Undisputed 01/23/2026 1103133475 CMS
ABBVIE INC. $450.00 06/05/2024 Consulting Fee Undisputed 01/23/2026 1103133477 CMS
ABBVIE INC. $85.03 06/27/2024 Food and Beverage Undisputed 01/23/2026 1103607296 CMS
ABBVIE INC. $97.61 07/19/2024 Food and Beverage Undisputed 01/23/2026 1103607298 CMS
ABBVIE INC. $3,300.00 12/13/2024 Consulting Fee Undisputed 01/23/2026 1103133479 CMS
ABBVIE INC. $2,200.00 12/31/2024 Consulting Fee Undisputed 01/23/2026 1103133481 CMS
ADC Therapeutics America, Inc. $3.59 01/17/2024 Food and Beverage Undisputed 01/23/2026 1121191795 CMS
ADC Therapeutics America, Inc. $23.58 07/11/2024 Food and Beverage Undisputed 01/23/2026 1121191833 CMS
ADC Therapeutics America, Inc. $123.96 09/19/2024 Food and Beverage Undisputed 01/23/2026 1121191897 CMS
ADC Therapeutics America, Inc. $150.00 12/08/2024 Food and Beverage Undisputed 01/23/2026 1121191919 CMS
BeiGene USA, Inc. $19.36 03/22/2024 Food and Beverage Undisputed 01/23/2026 1120849256 CMS
BeiGene USA, Inc. $20.37 05/24/2024 Food and Beverage Undisputed 01/23/2026 1120849260 CMS
BeiGene USA, Inc. $20.12 11/01/2024 Food and Beverage Undisputed 01/23/2026 1120849258 CMS
Celgene Corporation $21.00 06/01/2024 Food and Beverage Undisputed 01/23/2026 1101078512 CMS
Celgene Corporation $86.67 06/26/2024 Food and Beverage Undisputed 01/23/2026 1101078514 CMS
Celgene Corporation $49.47 07/21/2024 Food and Beverage Undisputed 01/23/2026 1101078518 CMS
Celgene Corporation $92.19 12/09/2024 Food and Beverage Undisputed 01/23/2026 1101078522 CMS
E.R. Squibb & Sons, L.L.C. $247.00 02/15/2024 Consulting Fee Undisputed 01/23/2026 1101207064 CMS
E.R. Squibb & Sons, L.L.C. $1,482.00 09/10/2024 Consulting Fee Undisputed 01/23/2026 1101207080 CMS
E.R. Squibb & Sons, L.L.C. $370.50 10/21/2024 Consulting Fee Undisputed 01/23/2026 1101207088 CMS
Genentech USA, Inc. $71.63 12/07/2024 Food and Beverage Undisputed 01/23/2026 1132985026 CMS
Genentech, Inc. $93.79 02/29/2024 Food and Beverage Undisputed 01/23/2026 1132985030 CMS
Genmab U.S., Inc. $27.34 01/11/2024 Food and Beverage Undisputed 01/23/2026 1126825181 CMS
Genmab U.S., Inc. $31.01 11/14/2024 Food and Beverage Undisputed 01/23/2026 1126825183 CMS
GlaxoSmithKline, LLC. $94.96 12/06/2024 Food and Beverage Undisputed 01/23/2026 1116573073 CMS
Janssen Scientific Affairs, LLC $26.95 08/06/2024 Food and Beverage Undisputed 01/23/2026 1078851246 CMS
Kite Pharma, Inc. $136.11 11/15/2024 Food and Beverage Undisputed 01/23/2026 1128613069 CMS
Regeneron Pharmaceuticals, Inc. $895.86 04/10/2024 Travel and Lodging Undisputed 01/23/2026 1114397975 CMS
Regeneron Pharmaceuticals, Inc. $35.25 04/10/2024 Travel and Lodging Undisputed 01/23/2026 1114397977 CMS
Regeneron Pharmaceuticals, Inc. $35.25 04/10/2024 Travel and Lodging Undisputed 01/23/2026 1114397979 CMS
Regeneron Pharmaceuticals, Inc. $364.70 04/10/2024 Travel and Lodging Undisputed 01/23/2026 1114397981 CMS
Regeneron Pharmaceuticals, Inc. $192.66 04/17/2024 Travel and Lodging Undisputed 01/23/2026 1114397983 CMS
Regeneron Pharmaceuticals, Inc. $239.19 04/17/2024 Food and Beverage Undisputed 01/23/2026 1114397985 CMS
Regeneron Pharmaceuticals, Inc. $57.89 04/17/2024 Food and Beverage Undisputed 01/23/2026 1114397987 CMS
Regeneron Pharmaceuticals, Inc. $38.05 04/17/2024 Food and Beverage Undisputed 01/23/2026 1114397989 CMS
Regeneron Pharmaceuticals, Inc. $75.27 04/17/2024 Food and Beverage Undisputed 01/23/2026 1114397991 CMS
Regeneron Pharmaceuticals, Inc. $38.05 04/17/2024 Food and Beverage Undisputed 01/23/2026 1114397993 CMS
Regeneron Pharmaceuticals, Inc. $28.95 04/17/2024 Food and Beverage Undisputed 01/23/2026 1114397995 CMS
Regeneron Pharmaceuticals, Inc. $329.50 06/21/2024 Consulting Fee Undisputed 01/23/2026 1114397997 CMS
Regeneron Pharmaceuticals, Inc. $2,636.00 06/21/2024 Consulting Fee Undisputed 01/23/2026 1114397999 CMS
Regeneron Pharmaceuticals, Inc. $2,636.00 06/21/2024 Consulting Fee Undisputed 01/23/2026 1114398001 CMS
Regeneron Pharmaceuticals, Inc. $46.00 06/21/2024 Travel and Lodging Undisputed 01/23/2026 1114398003 CMS
Regeneron Pharmaceuticals, Inc. $14.93 06/21/2024 Food and Beverage Undisputed 01/23/2026 1114398005 CMS
Regeneron Pharmaceuticals, Inc. $6.66 06/21/2024 Food and Beverage Undisputed 01/23/2026 1114398007 CMS
TAIHO ONCOLOGY, INC. $1,100.00 02/22/2024 Consulting Fee Undisputed 01/23/2026 1137941496 CMS

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-01-23
Program years on this page
2018, 2019, 2020, 2021, 2022, 2023, 2024
Source files
Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
Generated from
OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.